The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Influences on GPs' decision to prescribe new drugs--the importance of who says what
Open accessAbstract
OBJECTIVES: The aim of this study was to understand the range of factors that influence GPs' uptake of new drugs METHODS: A total of 107 GPs selected purposively from high, medium and low new drug prescribing practices in two health authorities in the north west of England were interviewed using the critical incident technique with semi-structured interviews. Interview topics included reasons for prescribing new drugs launched between January 1998 and May 1999; reasons for prescribing the new drug rather than alternatives; and sources of information used for each prescribed drug. RESULTS: Important biomedical influences were the failure of current therapy and adverse effect profile. More influential than these, however, was the pharmaceutical representative. Hospital consultants and observation of hospital prescribing was cited next most frequently. Patient request for a drug, and patient convenience and acceptability were also likely to influence new drug uptake. Written information was of limited importance except for local guidelines. GPs were largely reactive and opportunistic recipients of new drug information, rarely reporting an active information search. The decision to initiate a new drug is heavily influenced by 'who says what', in particular the pharmaceutical industry, hospital consultants and patients. The decision to 'adopt' a new drug is clinched by subsequent personal clinical experience. CONCLUSIONS: Prescribing of new drugs is not simply related to biomedical evaluation and critical appraisal but, more importantly, to the mode of exposure to pharmacological information and social influences on decision making. Viewed within this broad context, prescribing variation becomes more understandable. Findings have implications for the implementation of evidence-based medicine, which requires a multifaceted approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · Encyclopedia of Industrial and Organizational Psychology · doi:10.4135/9781412952651.n55 · Cited by 5,287
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Educational outreach visits: effects on professional practice and health care outcomes
O'Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A. D., Odgaard-Jensen, J., Kristoffersen, D. T., Forsetlund, L., Bainbridge, D., Freemantle, N., Davis, D., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000409.pub2 · Cited by 1,279
The emergence of the global fintech market: economic and technological determinants
Haddad, C., & Hornuf, L. (2019) · Small Business Economics · doi:10.1007/s11187-018-9991-x · Cited by 754
Cockburn, J., & Pit, S. (1997) · BMJ · doi:10.1136/bmj.315.7107.520 · Cited by 523
Why general practitioners do not implement evidence: qualitative study
Freeman, A. C., & Sweeney, K. (2001) · BMJ · doi:10.1136/bmj.323.7321.1100 · Cited by 400
The Accuracy of Drug Information From Pharmaceutical Sales Representatives
Ziegler, M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520400066047 · Cited by 297
Uncomfortable prescribing decisions: a critical incident study.
Bradley, C. P. (1992) · BMJ · doi:10.1136/bmj.304.6822.294 · Cited by 228
Mintzes, B. (2002) · BMJ · doi:10.1136/bmj.324.7332.278 · Cited by 227
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
Jones, M. I., Greenfield, S. M., & Bradley, C. P. (2001) · BMJ · doi:10.1136/bmj.323.7309.378 · Cited by 175
McGettigan, P., Golden, J., Fryer, J., Chan, R., & Feely, J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01332.x · Cited by 173
The role of commercial sources in the adoption of a new drug
Peay, M. Y., & Peay, E. R. (1988) · Social Science & Medicine · doi:10.1016/0277-9536(88)90149-9 · Cited by 139
A study of factors associated with cost and variation in prescribing among GPs
Carthy, P., Harvey, I. M., Brawn, R., & Watkins, C. (2000) · Family Practice · doi:10.1093/fampra/17.1.36 · Cited by 108
The myth of objectivity: is medicine moving towards a social constructivist medical paradigm?
Wilson, H. J. (2000) · Family Practice · doi:10.1093/fampra/17.2.203 · Cited by 105
The Influence of Hospital-Based Prescribers on Prescribing in General Practice
Feely, J., Chan, R. M. T., McManus, J., & Shea, B. O. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916020-00006 · Cited by 91
Explaining variations in prescribing costs across England.
Morton‐Jones, T., & Pringle, M. (1993) · BMJ · doi:10.1136/bmj.306.6894.1731 · Cited by 57
Cited by
Lamy, J.-B. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.07.002 · Cited by 358
Jansson, J., Nordlund, A., & Westin, K. (2017) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2017.03.186 · Cited by 286
Haider, S. I., Johnell, K., Weitoft, G. R., Thorslund, M., & Fastbom, J. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02040.x · Cited by 253
Beyond polemics: science and ethics of ADHD
Singh, I. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2514 · Cited by 233
Theodorou, M., Tsiantou, V., Pavlakis, A., Maniadakis, N., Fragoulakis, V., Pavi, E., & Kyriopoulos, J. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-150 · Cited by 124
Metadata
- Authors
- Prosser, H.
- Venue
- Family Practice
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01-01
- Volume
- 20
- Issue
- 1
- Pages
- 61-68
- ISSN
- 0263-2136 (ISSN-L)
- 1460-2229
- OpenAlex
- W2140082540
- Cited by
- 318
- References
- 16
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.